CYP7B1 and Hepatic failure: These patients lacking CYP7B1 activity are characterized by elevated levels of 24-HC, 25-HC, 27-HC, 3β-hydroxy-5-cholenoic and 3β-hydroxy-5-cholestenoic acids, aggressive hepatic fibrosis and inflammation that eventually lead to liver failure and premature death.